How deadly is Breast cancer?

Mazal tanhat n etari t aqqal a hin iknan tamattant?

Cancer n etari eqqal aṭṭan aśohen izar adobatnen ad iknu tamattant.

Eqal cancer wa ojjaran jir addinat win addinat daɣ alɣalim tolas eqqal s data s eqqal s eqqal s eqqal s eqqal s eqqal s eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal eqqal

Daɣ American Cancer Society, daɣ awatay wan 20220, illanat 276,480 n ihuk n tumast n etari eynaynen daɣ addinat daɣ Amrik tolas illanat 42,170 n addinat daɣ Amrik wi immuten s etari

Hak id ijja awen, iddikud n tamattant n cancer n etari eqqal a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan a eqqalan

Aśahat ən tamattant fal kansar ən tayəte izlay dǎɣ harat ən haratan sund tamudre, edag dǎɣ asiwad, əd dumu ən kansar ən tayəte.

Asukni d asafar n azzaman addoben ad issiwid hullan ijjan n tamudre

['Isalan wi illanen']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

van Schoor G, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R, Broeders MJ, Verbeek AL: Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer. 2011, 104 (6): 910-4.

DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL: Breast cancer statistics, 2019. CA Cancer J Clin. 2019, 69 (6): 438-451.

Icaza G, Núñez L, Bugueño H: [Epidemiological analysis of breast cancer mortality in women in Chile]. Rev Med Chil. 2017, 145 (1): 106-114.

Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, Kopans DB, Eby PR, Sickles EA: Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging. J Am Coll Radiol. 2017, 14 (9): 1137-1143.

Deaths from breast cancer--United States, 1991. MMWR Morb Mortal Wkly Rep. 1994, 43 (15): 273, 279-81.

Kuroishi T, Hirose K, Suzuki T, Tominaga S: Effectiveness of mass screening for breast cancer in Japan. Breast Cancer. 2000, 7 (1): 1-8.

['Asukni: medikal']

['Web site wen eqqal i isalan n teɣare d isalan ɣas tolas war eqqel asiwil n asafar meɣ alxidmat tan n musnat']

['Isalan wi ikfan war addoben ad axdaman i asifham meɣ asafar n aśahat meɣ aśahat tolas wi aramanen asiwil n asafar n awadim ilzam ad aruman asiwil n asafar n awadim']

['Dǎɣ asikin, neural net wa iknanen tirmawen ən assestan, eqal aśohen aśohat dǎɣ alwaq wa id itawan dǎɣ maɗin ən maɗinan. sund, iddikud ən adinat wi atiwasananen as aśohat atiwasanan.']

['Harkuk arha majrad n doctor inek meɣ n awadim n assexat n tazmert n addinat fal aśahat n aśahat. War t-id-t-igdel majrad n aśahat n awadim meɣ azzaman daɣ aśahat fal as harat awa iktabem fal site wen. Afal as ad t-illa aśahat n aśahat n aśahat, asiwel 911 meɣ aru s ehan n aśahat n aśahat wa oharnen daɣ azzaman. War t-illa majrad n aśahat n awadim d aśahat fal site wen meɣ axadam net. BioMedLib meɣ inaxdiman net meɣ awadim wa iknanen fal site wen, war t-illa majrad, iknan meɣ iknan, fal isalan wi dawanen meɣ axadam net']

['Asukni: copyright']

['Digital Millennium Copyright Act wan 1998, 17 U.S.C. § 512 (DMCA) eha almaɣna i kel alxaq n alxaq n alxaq wa allaɣen as isuj win illanen fal Internet ikna alxaq nasan daɣ achareɣa n alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq wan alxaq']

['A fal tazamt s tiditt as isalan meɣ isuj win illanen daɣ asuj n asuj net meɣ alxidmaten iknan alxaq inek n alxaq, addobat ad aɣ-d-tazneḍ (meɣ agent inek) isalan meɣ isuj win ad n-ikkes meɣ ad n-isikkid alxidmat']

['Isalan ilzam ad ittusiknan s eɣaf s email (ikayad edag "Contact" i tansa n email)']

['DMCA t-assirɣas as isalan inek n asiwad n alxaq n alxoriya eha isalan win: (1) almaɣna n alxidmat eha alxaq n alxoriya eqqal harat n asiwad eha alxaq n alxoriya; (2) almaɣna n almaɣna eha alxoriya d isalan ajjotnen ijjan aɣ ad n afhaman almaɣna; (3) isalan n alɣisab inek, ahan tansa, amaṭṭaf n tilifun d tansa n email inek; (4) almaɣna inek n as ilan tumast n alxaq n alxoriya as almaɣna wa s eha alxaq eha alxaq eha alxaq war eha alxaq n alxaq eha alxoriya meɣ amatikki net meɣ s alxidmat n achareɣa fuk']

['(5) almaɣna n awen, iktab daɣ azruf n alkad n tiditt, as isalan win isalan aqqalan tiditt tolas ilan tanaya n as artay alxaqqan win alxakum wi s allaɣen as ikna']

['Dǎɣ awa, əmik ən əmik ən alxaq meɣ awadim ən alxaq ən alxaq meɣ awadim atiwafan ye igi ən alxaq ən alxaq.']

['A fal war t-id-t-id-t-id-t-id-t-id-t-id-t-id-t-id-t-id-t-id-t-id-t-id-t-id-t-id-t-id-t-id-t-id-t-id-t-id-t-id-t-id']

['Assahat']

['Ilzam aɣ e-mail s asteqsi meɣ asukni']

How deadly is breast cancer?

Breast cancer is a serious and potentially deadly disease.

It is the most common cancer among women worldwide and the second leading cause of cancer death in women.

According to the American Cancer Society, in 20220, an estimated 276,480 new cases of invasive breast cancer were diagnosed in women in the United States, and about 42,170 women in the U.S. died from breast cancer.

However, the death rate from breast cancer has been declining since 1989, with a 40% decrease in the breast cancer death rate from 1989 to 2017, largely due to improvements in early detection and treatment.

The risk of dying from breast cancer varies depending on factors such as age, stage at diagnosis, and the type of breast cancer.

Early detection and treatment can significantly improve the chances of survival.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.